8. Cardiovascular Disease and Risk Management

被引：192

作者：

不详

机构：

来源：

DIABETES CARE | 2016年 / 39卷

关键词：

TYPE-2; DIABETES-MELLITUS; CORONARY-HEART-DISEASE; VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; STATIN-INTOLERANT PATIENTS; LOWERING LDL CHOLESTEROL; BLOOD-PRESSURE CONTROL; 14; RANDOMIZED-TRIALS; PRIMARY PREVENTION; ASYMPTOMATIC PATIENTS;

D O I：

10.2337/dc16-S011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S60 / S71

页数：12

共 105 条

[1] Blood pressure targets for hypertension in people with diabetes mellitus [J].

Agustin Arguedas, Jose ;

Leiva, Viriam ;

Wright, James M. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (10)

[2] Achievement of Goals in U.S. Diabetes Care, 1999-2010 [J].

Ali, Mohammed K. ;

Bullard, Kai McKeever ;

Saaddine, Jinan B. ;

Cowie, Catherine C. ;

Imperatore, Giuseppina ;

Gregg, Edward W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (17) :1613-1624

[3]

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981

[4] Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy [J].

Anand, DV ;

Lim, E ;

Hopkins, D ;

Corder, R ;

Shaw, LJ ;

Sharp, P ;

Lipkin, D ;

Lahiri, A .

EUROPEAN HEART JOURNAL, 2006, 27 (06) :713-721

[5] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[6] A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease [J].

Frye R.L. ;

August P. ;

Brooks M.M. ;

Hardison R.M. ;

Kelsey S.F. ;

MacGregor J.M. ;

Orchard T.J. ;

Chaitman B.R. ;

Genuth S.M. ;

Goldberg S.H. ;

Hlatky M.A. ;

Jones T.L.Z. ;

Molitch M.E. ;

Nesto R.W. ;

Sako E.Y. ;

Sobel B.E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (24) :2503-2515

[7] The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease [J].

Belch, Jill ;

MacCuish, Angus ;

Campbell, Iain ;

Cobbe, Stuart ;

Taylor, Roy ;

Prescott, Robin ;

Lee, Robert ;

Bancroft, Jean ;

MacEwan, Shirley ;

Shepherd, James ;

Macfarlane, Peter ;

Morris, Andrew ;

Jung, Roland ;

Kelly, Christopher ;

Connacher, Alan ;

Peden, Norman ;

Jamieson, Andrew ;

Matthews, David ;

Leese, Graeme ;

McKnight, John ;

O'Brien, Iain ;

Semple, Colin ;

Petrie, John ;

Gordon, Derek ;

Pringle, Stuart ;

MacWalter, Ron .

BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 :a1840

[8] Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline [J].

Berglund, Lars ;

Brunzell, John D. ;

Goldberg, Anne C. ;

Goldberg, Ira J. ;

Sacks, Frank ;

Murad, Mohammad Hassan ;

Stalenhoef, Anton F. H. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09) :2969-2989

[9] Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy [J].

Berl, T ;

Hunsicker, LG ;

Lewis, JB ;

Pfeffer, MA ;

Porush, JG ;

Rouleau, JL ;

Drury, PL ;

Esmatjes, E ;

Hricik, D ;

Parikh, CR ;

Raz, I ;

Vanhille, P ;

Wiegmann, TB ;

Wolfe, BM ;

Locatelli, F ;

Goldhaber, SZ ;

Lewis, EJ .

ANNALS OF INTERNAL MEDICINE, 2003, 138 (07) :542-549

[10] Randomized controlled trial comparing impact on platelet reactivity of twice-daily with once-daily aspirin in people with Type 2 diabetes [J].

Bethel, M. A. ;

Harrison, P. ;

Sourij, H. ;

Sun, Y. ;

Tucker, L. ;

Kennedy, I. ;

White, S. ;

Hill, L. ;

Oulhaj, A. ;

Coleman, R. L. ;

Holman, R. R. .

DIABETIC MEDICINE, 2016, 33 (02) :224-230

← 1 2 3 4 5 6 7 8 9 10 →